Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association

被引：222
作者：
Wiggins, Barbara S. [1 ]
Saseen, Joseph J. [2 ]
Page, Robert L., II [2 ]
Reed, Brent N. [5 ]
Sneed, Kevin [6 ]
Kostis, John B. [3 ]
Lanfear, David [4 ]
Virani, Salim [7 ]
Morris, Pamela B. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[3] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[4] Henry Ford Hosp, Detroit, MI 48202 USA
[5] Univ Maryland, Sch Pharm, College Pk, MD 20742 USA
[6] Univ S Florida, Coll Pharm, Tampa, FL USA
[7] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA
来源：
CIRCULATION | 2016年 / 134卷 / 21期
关键词：
AHA Scientific Statements; anti-arrhythmic agents; anticoagulants; calcium channel blockers; cardiovascular disease; drug-related side effects and adverse reactions; fenofibrate/fenofibric acid derivatives; gemfibrozil; hydroxymethylglutaryl-CoA reductase inhibitors; immunosuppressive agents; COA REDUCTASE INHIBITORS; SIGNIFICANT PHARMACOKINETIC INTERACTION; TYPE-2; DIABETES-MELLITUS; LIPID-LOWERING DRUGS; CONCOMITANT USE; MYOCARDIAL-INFARCTION; P-GLYCOPROTEIN; PLASMA-CONCENTRATIONS; RANDOMIZED-TRIAL; HOSPITALIZED RHABDOMYOLYSIS;
D O I：
10.1161/CIR.0000000000000456
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E468 / E495
页数：28
相关论文
共 187 条
  • [1] Abbvie Inc, TRILIPIX FEN AC CAPS
  • [2] Abbvie Inc, TRICOR FEN TABL
  • [3] LOVASTATIN - WARFARIN INTERACTION
    AHMAD, S
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (11) : 2407 - 2407
  • [4] Acute myopathy in a patient with concomitant use of pravastatin and colchicine
    Alayli, G
    Cengiz, K
    Cantürk, F
    Durmus, D
    Akyol, Y
    Menekse, EB
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1358 - 1361
  • [5] Safety and Efficacy of Statin Therapy in Patients Switched From Cyclosporine A to Sirolimus After Cardiac Transplantation
    Aliabadi, Arezu Z.
    Mahr, Stephane
    Dunkler, Daniela
    Groemmer, Martina
    Zimpfer, Daniel
    Wolner, Ernst
    Grimm, Michael
    Zuckermann, Andreas O.
    [J]. TRANSPLANTATION, 2008, 86 (12) : 1771 - 1776
  • [6] ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
  • [7] Risk of adverse events with fibrates
    Alsheikh-Ali, AA
    Kuvin, JT
    Karas, RH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) : 935 - +
  • [8] Alsheikh-Ali Alawi A, 2005, Prev Cardiol, V8, P95, DOI 10.1111/j.1520-037X.2005.4060.x
  • [9] Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population
    Amend, Kandace L.
    Landon, Joan
    Thyagarajan, Veena
    Niemcryk, Steve
    McAfee, Andrew
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1230 - 1239
  • [10] Andersson ML, 2012, PHARMACOGENOMICS, V13, P757, DOI [10.2217/PGS.12.40, 10.2217/pgs.12.40]
12345678910